Cardinal Health Inc. (NYSE:CAH) finished Tuesday with a subtraction of -$0.52 to close at $48.66, a downside of -1.06 percent. An average of 5,799,880 shares of common stock have been traded in the last five days. There was a fall of -$2.93 in the past week. The last 20 days have seen an average of 3,959,535 shares traded, while the 50-day average volume stands at 3,191,416.
CAH stock has decreased by -9.42% in the last month. The company shares reached their 1-month lowest point of $47.74 on 10/06/21. With the stock rallying to its 52-week high on 03/30/21, shares of the company touched a low of $44.92 and a high of $62.96 in 52 weeks. In spite of this, the price is down -22.71% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
223 days have passed since Cardinal Health Inc. (CAH) last reported insider trading activity. Mayer Jessica L, who is Chief Legal/Compliance Officer, most recently acquired $3,500 shares at $51.53 per share on Feb 26. In this transaction, the insider spent $180,355. Chief Accounting Officer, English Patricia M, disposed of 3,291 shares at a price of $51.98 on Feb 11. The insider now owns more than $171,066 worth of shares.
Cardinal Health Inc. (CAH) has a trailing price-to-earnings (P/E) ratio of 23.53, which compares with the 25.20 for the broader industry and 31.71 for the sector. This means investors are optimistic about the stock’s future prospects. In the last five years, Cardinal Health Inc.’s PE ratio has ranged between 501.40 and 9.110. The stock’s beta is 1.04. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.08, the price-to-book (PB) ratio at 7.85, and the price-to-cash flow ratio at 10.14.
Cardinal Health Inc. pays a $1.96 dividend per share annually. It offers a dividend yield of 4.03%. The company has a payout ratio of 93.20%. The company’s most recent quarterly dividend payment was $0.4910 a share, representing a up of 0.04 from $0.4908 last year. Its dividend has been increased for the last 34 consecutive years with the latest increase dividend $0.0002 reported on Thursday August 5 2021. Dividends have grown by 5.59% each year over the last three years.
Cardinal Health Inc. will next go ex-dividend on 31-Dec-2021. The next dividend payment Cardinal Health Inc. will make is expected to be $0.4908.
The quick ratio of Cardinal Health Inc. for the three months ended June 29 was 0.60, and the current ratio was 1.10, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 3.00 and a total debt to equity ratio of 3.48 for the quarter ending June 29. On the profitability front, the trailing 12-month gross margin is 4.20% against a 5-year average of 4.7%. Cardinal Health Inc.’s EBITDA margin for the year ending June 29 is 1.61%, while its operating margin for the same period stands at 0.30%. Its gross profit as reported stood at $6.78 billion compared to revenue of $162.47 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Cardinal Health Inc.’s return on assets was 1.40%, compared to 0.0% over the last five years. In the past year, the return on investment has been 9.30%, and the 5-year average is 0.4%. Meanwhile, the return on equity (ROE) for the past 12 months has been 35.00% and the 5-year average holds at -2.3%. For the broader industry, ROE averaged 1.09 over the past year.
The analyst consensus anticipated Cardinal Health Inc.’s latest quarter earnings to come in at $1.2 per share, but it turned out to be $0.77, a -35.80% surprise. For the quarter, EBITDA amounted to $342.0 million. Shareholders own equity worth $290.44 million.
From a technical analysis perspective, let’s take a brief look at Cardinal Health Inc. (CAH) price momentum. RSI 9-day as of the close on 05 October was 25.97%, suggesting the stock is oversold, with historical volatility in this time frame at 23.08%.
As of today, CAH’s price is $49.37 -5.68% or -$2.93 from its 5-day moving average. CAH is currently trading -9.03% lower than its 20-day SMA and -13.63% lower than its 100-day SMA. However, the stock’s current price level is -18.11% below the SMA50 and -11.46% below the SMA200.
The stochastic %K and %D were 12.76% and 14.06%, respectively, and the average true range (ATR) was 1.17. With the 14-day stochastic at 16.00% and the average true range at 1.14, the RSI (14) stands at 30.29%. The stock has reached -1.13 on the 9-day MACD Oscillator while the 14-day reading was at -1.58.
Deutsche Bank downgraded Cardinal Health Inc. (NYSE: CAH) to a a Hold rating in its most recent analyst report. Previously, the stock was rated as a a Buy.The consensus rating for Cardinal Health Inc. (CAH) among analysts is Hold. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CAH, while 10 suggest investors hold. There are 1 analyst who rate the stock as underweight. The stock is rated overweight by 2 analysts, while 2 others rate it as a “buy”.
What is CAH’s price target for the next 12 months?
Analysts predict a range of price targets between $50.00 and $68.00, with a median target of $56.00. Taking a look at these predictions, the average price target given by analysts for Cardinal Health Inc. (CAH) stock is $57.92.